Concept Identification, Analysis, Middle Range Theory Development, and Clinical Application
By defining, describing, and analyzing concepts, nurse scholars can develop a better understanding of how events and experiences, important to advanced
practice nursing, are related to other concepts. This understanding can be used to develop middle-range theories which can focus nursing assessments and can
be tested through research to develop evidence-based interventions.
Watch the film “Breathing Lessons: The Life of Mark O’Brien” as a case study which you can find on the internet.
Make a list of all of the concepts that you identify as relevant to the nursing care of Mark.
Select from your list, three concepts that you believe are related and provide a conceptual definition of each concept based on a review of the literature.
Write a statement that:
Names your middle range theory
Identifies the propositions or relationships among the concepts
Draw a conceptual map that illustrates how the concepts are related.
Apply knowledge of characteristics of the three concepts in formulating at least three nursing assessment questions related to each of the concepts of your
middle-range theory.
Compare your middle range theory with a published theory that may also be of value in guiding advanced practice nursing in the care of Mark O’Brien nursing
based on the literature. Is your thinking consistent with another theorist’s theory? (Provide Reference APA).
To finish up, the central matters that have been talked about right now the significance of various types of correspondence in nursing and how they can be used for a restorative medical caretaker persistent relationship. Poor relational abilities are as yet present and medical attendants must plan to be increasingly compassionate to give quality comprehensive consideration
10.
In a couple of studies, it has been demonstrated that B. subtilis separates can blend protein anti-infection agents, similar to subtilin, subtilosin and sublancin, which are for the most part dynamic against Gram-positive microorganisms (42-44). This is steady with our outcomes in the opposite streak test where secludes 102 and 104 just repressed the development of Gram-positive test creatures. Subtilosin An is one of the anti-infection agents orchestrated by B. subtilis, it has exhibited to be dynamic against a wide scope of microscopic organisms, including Listeria monocytogenes, E. coli, S. aureus, and K. pneumoniae, in spite of the fact that its impact on human pathogenic microscopic organisms was moderate (45). Other than antibacterial movement, both B. subtilis and B. velezensis additionally produce antifungal lipopeptides, for example, iturin, bacillomycin, and fengycin, where strains of B. subtilis have exhibited solid antifungal properties against Aspergillus ochraceus, Penicillium roqueforti, and strains of B. velezensis were dynamic against Alternaria panax and Magnaporthe oryzae. (12; 46; 47).
16S rRNA succession of segregate 107 has proposed it to be B. pumilus. Constrained examinations have been directed utilizing B. pumilus, particularly against human pathogens. Be that as it may, it was discovered that one strain of B. pumilus created pumilicin 4, a bacteriocin with great warmth and pH soundness, and has movement against a huge range of Gram-positive microbes, including MRSA and VRE (48). In the present investigation, separate 104 has shown antibacterial activity just against Gram-positive microscopic organisms, which is as opposed to a couple of studies which have detailed that B. pumilus demonstrated restraint against both Gram-positive (eg: MSSA) and Gram-negative microscopic organisms (eg: E. coli) (49; 50). This shows B. pumilus might deliver more than one sort of bioactive mixes (eg: pumilicin, surfactin, iturin) which are dynamic against various classes of microbes (46; 50). The strain of B. pumilus secluded in our examination likewise indicated ground-breaking restraint against various strains of E. coli. Bacillus species is generally explored for its viability against pathogenic organisms and plant ailment, however just a couple of studies have been done on human pathogenic microorganisms which thwart us from making a valuable end that can add to the medication innovative work.
